How it works, simply
The long-acting form studied in human trials prolonged growth hormone and IGF-1 responses.
What the evidence tells us
Short randomized studies measured prolonged growth hormone and IGF-1 responses in healthy adults. They did not establish long-term muscle gain, recovery or anti-aging outcomes.
Those hormone measurements do not establish muscle or anti-aging benefits. Products sold as no-DAC are not the same studied formulation.
Watch with PEP 7
A short introduction; the sources and limitations remain important.
Open video guide
Video guides are coming soon.
Risks and open questions
This guide does not establish a safe dose, interaction profile or long-term safety for self-use. Effects reported for one route or formulation may not apply to another.
Research and education only. PepGuide does not recommend medicines, doses or protocols.
Technical details and study context
Mechanism: Activates the growth hormone-releasing hormone receptor; marketed identity and DAC status can be ambiguous.
Sponsor or developer: No approved-product sponsor
Studied or labeled topics: Growth hormone claims, Body-composition claims
Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.
Sources and review dates
- Randomized CJC-1295 hormone-response trials ↗ · Research paper · 2006
- FDA: CJC-1295 safety concerns ↗ · Regulator
Product labels and further research
These directories help locate records. They are not individual studies supporting every statement.
Readability updated October 10, 2026. Evidence review: October 10, 2026 (listed study and FDA safety context). A wording update is not a new clinical review.